BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21420984)

  • 21. Interaction of cocaine and dopamine transporter inhibitors on behavior and neurochemistry in monkeys.
    Ginsburg BC; Kimmel HL; Carroll FI; Goodman MM; Howell LL
    Pharmacol Biochem Behav; 2005 Mar; 80(3):481-91. PubMed ID: 15740791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Labeling of dopamine transporter transmembrane domain 1 with the tropane ligand N-[4-(4-azido-3-[125I]iodophenyl)butyl]-2beta-carbomethoxy-3beta-(4-chlorophenyl)tropane implicates proximity of cocaine and substrate active sites.
    Parnas ML; Gaffaney JD; Zou MF; Lever JR; Newman AH; Vaughan RA
    Mol Pharmacol; 2008 Apr; 73(4):1141-50. PubMed ID: 18216182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distribution of cocaine recognition sites in rat brain: in vitro and ex vivo autoradiography with [125I]RTI-55.
    Fujita M; Shimada S; Fukuchi K; Tohyama M; Nishimura T
    J Chem Neuroanat; 1994 Jul; 7(1-2):13-23. PubMed ID: 7802967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-substituted phenyltropanes as in vivo binding ligands for rapid imaging studies of the dopamine transporter.
    Scheffel U; Lever JR; Abraham P; Parham KR; Mathews WB; Kopajtic T; Carroll FI; Kuhar MJ
    Synapse; 1997 Apr; 25(4):345-9. PubMed ID: 9097393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies of the biogenic amine transporters. VI. Characterization of a novel cocaine binding site, identified with [125I]RTI-55, in membranes prepared from whole rat brain minus caudate.
    Rothman RB; Silverthorn ML; Baumann MH; Goodman CB; Cadet JL; Matecka D; Rice KC; Carroll FI; Wang JB; Uhl GR
    J Pharmacol Exp Ther; 1995 Jul; 274(1):385-95. PubMed ID: 7616423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies of the biogenic amine transporters. IV. Demonstration of a multiplicity of binding sites in rat caudate membranes for the cocaine analog [125I]RTI-55.
    Rothman RB; Cadet JL; Akunne HC; Silverthorn ML; Baumann MH; Carroll FI; Rice KC; de Costa BR; Partilla JS; Wang JB
    J Pharmacol Exp Ther; 1994 Jul; 270(1):296-309. PubMed ID: 8035327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.
    Han DD; Gu HH
    BMC Pharmacol; 2006 Mar; 6():6. PubMed ID: 16515684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visualization of dopamine transporter trafficking in live neurons by use of fluorescent cocaine analogs.
    Eriksen J; Rasmussen SG; Rasmussen TN; Vaegter CB; Cha JH; Zou MF; Newman AH; Gether U
    J Neurosci; 2009 May; 29(21):6794-808. PubMed ID: 19474307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitive effects of Fructus Psoraleae extract on dopamine transporter and noradrenaline transporter.
    Zhao G; Li S; Qin GW; Fei J; Guo LH
    J Ethnopharmacol; 2007 Jul; 112(3):498-506. PubMed ID: 17555897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies of the biogenic amine transporters 15. Identification of novel allosteric dopamine transporter ligands with nanomolar potency.
    Rothman RB; Ananthan S; Partilla JS; Saini SK; Moukha-Chafiq O; Pathak V; Baumann MH
    J Pharmacol Exp Ther; 2015 Jun; 353(3):529-38. PubMed ID: 25788711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, monoamine transporter binding properties, and behavioral pharmacology of a series of 3beta-(substituted phenyl)-2beta-(3'-substituted isoxazol-5-yl)tropanes.
    Carroll FI; Pawlush N; Kuhar MJ; Pollard GT; Howard JL
    J Med Chem; 2004 Jan; 47(2):296-302. PubMed ID: 14711303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The binding sites for cocaine and dopamine in the dopamine transporter overlap.
    Beuming T; Kniazeff J; Bergmann ML; Shi L; Gracia L; Raniszewska K; Newman AH; Javitch JA; Weinstein H; Gether U; Loland CJ
    Nat Neurosci; 2008 Jul; 11(7):780-9. PubMed ID: 18568020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity relationship studies of 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives and their N-analogues: evaluation of O-and N-analogues and their binding to monoamine transporters.
    Dutta AK; Fei XS; Beardsley PM; Newman JL; Reith ME
    J Med Chem; 2001 Mar; 44(6):937-48. PubMed ID: 11300876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 [3 beta-(3p-chlorophenyl) tropan-2 beta-carboxylic acid p-isothiocyanatophenylethyl ester hydrochloride].
    Fleckenstein AE; Pögün S; Carroll FI; Kuhar MJ
    J Pharmacol Exp Ther; 1996 Oct; 279(1):200-6. PubMed ID: 8858994
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple binding sites for [125I]RTI-121 and other cocaine analogs in rat frontal cerebral cortex.
    Boja JW; Carroll FI; Vaughan RA; Kopajtic T; Kuhar MJ
    Synapse; 1998 Sep; 30(1):9-17. PubMed ID: 9704876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of intracellular residues in the dopamine transporter critical for regulation of transporter conformation and cocaine binding.
    Loland CJ; Grånäs C; Javitch JA; Gether U
    J Biol Chem; 2004 Jan; 279(5):3228-38. PubMed ID: 14597628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membrane cholesterol modulates the outward facing conformation of the dopamine transporter and alters cocaine binding.
    Hong WC; Amara SG
    J Biol Chem; 2010 Oct; 285(42):32616-26. PubMed ID: 20688912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RTI-76, an isothiocyanate derivative of a phenyltropane cocaine analog, as a tool for irreversibly inactivating dopamine transporter function in vitro.
    Wang LC; Berfield JL; Kuhar MJ; Carroll FI; Reith ME
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Sep; 362(3):238-47. PubMed ID: 10997726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.
    Kotturi SV; Jiang S; Chang AC; Abraham P; Navarro HA; Kuhar MJ; Carroll FI
    J Med Chem; 2005 Nov; 48(23):7437-44. PubMed ID: 16279803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substrates and inhibitors display different sensitivity to expression level of the dopamine transporter in heterologously expressing cells.
    Chen N; Reith ME
    J Neurochem; 2007 Apr; 101(2):377-88. PubMed ID: 17250655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.